Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop.

OA: gold CC-BY-NC-4.0
📄 Open PDF View on PubMed View at publisher

My notes (saved in your browser only)

Funding

funders
[{'doi': '10.13039/501100005026', 'name': 'Stichting Tegen Kanker', 'awards': ['TRPM3']}, {'doi': '10.13039/501100005690', 'name': 'Universität des Saarlandes', 'awards': []}, {'doi': '10.13039/501100005026', 'name': 'Stichting Tegen Kanker', 'awards': []}, {'doi': '10.13039/100017885', 'name': 'Queen\xa0Elisabeth\xa0Medical\xa0Foundation', 'awards': []}, {'doi': '10.13039/501100003130', 'name': 'Fonds Wetenschappelijk Onderzoek', 'awards': ['G.0B1819N']}, {'doi': '10.13039/501100003130', 'name': 'Fonds Wetenschappelijk Onderzoek', 'awards': ['G.084515N']}, {'doi': '10.13039/501100003130', 'name': 'Fonds Wetenschappelijk Onderzoek', 'awards': ['G.0825.11']}, {'doi': '10.13039/501100003130', 'name': 'Fonds Wetenschappelijk Onderzoek', 'awards': ['G.0565.07']}, {'doi': '10.13039/100018214', 'name': 'Belgische Federale Overheidsdiensten', 'awards': ['IUAP P7/13']}]

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (35)

Source provenance

crossref
last seen: 2026-06-12T06:26:16.160161+00:00
europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
unpaywall
last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-NC-4.0